Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Related Citations for PubMed (Select 24937957)

1.

Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.

Barber EL, Schink JC, Lurain JR.

J Reprod Med. 2014 May-Jun;59(5-6):199-203.

PMID:
24937957
2.

Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.

Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, Kose MF.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1432-8.

PMID:
16803542
4.

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.

Lybol C, Centen DW, Thomas CM, ten Kate-Booij MJ, Verheijen RH, Sweep FC, Ottevanger PB, Massuger LF.

BJOG. 2012 Nov;119(12):1465-72. doi: 10.1111/j.1471-0528.2012.03480.x. Epub 2012 Aug 24.

PMID:
22925191
5.

Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.

Lurain JR, Singh DK, Schink JC.

J Reprod Med. 2006 Oct;51(10):767-72.

PMID:
17086804
6.

Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.

Fülöp V, Szigetvári I, Szepesi J, Végh G, Singh M, Berkowitz RS.

J Reprod Med. 2012 Jul-Aug;57(7-8):310-8.

PMID:
22838247
7.

Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary.

Fülöp V, Szigetvári I, Szepesi J, Végh G, Berkowitz RS.

J Reprod Med. 2014 May-Jun;59(5-6):227-34.

PMID:
24937962
8.

Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.

Lurain JR, Chapman-Davis E, Hoekstra AV, Schink JC.

J Reprod Med. 2012 Jul-Aug;57(7-8):283-7.

PMID:
22838241
9.

Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.

Agarwal R, Alifrangis C, Everard J, Savage PM, Short D, Tidy J, Fisher RA, Sebire NJ, Harvey R, Hancock BW, Coleman RE, Seckl MJ.

J Reprod Med. 2014 Jan-Feb;59(1-2):7-12.

PMID:
24597279
10.
11.

Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.

Deng L, Zhang J, Wu T, Lawrie TA.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD005196. doi: 10.1002/14651858.CD005196.pub4. Review.

PMID:
23440800
12.

EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.

Han SN, Amant F, Leunen K, Devi UK, Neven P, Vergote I.

Int J Gynecol Cancer. 2012 Jun;22(5):875-80. doi: 10.1097/IGC.0b013e31824d834d.

PMID:
22635033
13.

Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.

Lurain JR, Schink JC.

J Reprod Med. 2012 May-Jun;57(5-6):219-24.

PMID:
22696816
14.

Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.

Fülöp V, Szigetvŕi I, Szepesi J, Török M, Berkowitz RS.

J Reprod Med. 2008 Jul;53(7):541-6.

PMID:
18720931
15.

High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.

Chauhan A, Dave K, Desai A, Mankad M, Patel S, Dave P.

J Reprod Med. 2010 Jul-Aug;55(7-8):333-40.

PMID:
20795348
16.

Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia.

Cyriac S, Rajendranath R, Sridevi V, Sagar TG.

Int J Gynaecol Obstet. 2011 Oct;115(1):37-9. doi: 10.1016/j.ijgo.2011.04.017. Epub 2011 Jul 29.

PMID:
21802685
17.

Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.

Bianconi MI, Otero S, Moscheni O, Alvarez L, Storino C, Jankilevich G.

J Reprod Med. 2012 Jul-Aug;57(7-8):341-9.

PMID:
22838252
18.
19.

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.

Chapman-Davis E, Hoekstra AV, Rademaker AW, Schink JC, Lurain JR.

Gynecol Oncol. 2012 Jun;125(3):572-5. doi: 10.1016/j.ygyno.2012.03.039. Epub 2012 Mar 23.

PMID:
22449733
20.

Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.

Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV, Berkowitz RS.

J Reprod Med. 2012 Jul-Aug;57(7-8):305-9.

PMID:
22838246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk